Stock Research for AERI

AERI

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AERI Stock Chart & Research Data

The AERI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AERI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AERI Due diligence Resources & Stock Charts

The AERI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AERI Detailed Price Forecast - CNN Money CNN View AERI Detailed Summary - Google Finance
Yahoo View AERI Detailed Summary - Yahoo! Finance Zacks View AERI Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View AERI Trends & Analysis - Trade-Ideas Barrons View AERI Major Holders - Barrons
NASDAQ View AERI Call Transcripts - NASDAQ Seeking View AERI Breaking News & Analysis - Seeking Alpha
Spotlight View AERI Annual Report - CompanySpotlight.com OTC Report View AERI OTC Short Report - OTCShortReport.com
TradeKing View AERI Fundamentals - TradeKing Charts View AERI SEC Filings - Bar Chart
WSJ View Historical Prices for AERI - The WSJ Morningstar View Performance/Total Return for AERI - Morningstar
MarketWatch View the Analyst Estimates for AERI - MarketWatch CNBC View the Earnings History for AERI - CNBC
StockMarketWatch View the AERI Earnings - StockMarketWatch MacroAxis View AERI Buy or Sell Recommendations - MacroAxis
Bullish View the AERI Bullish Patterns - American Bulls Short Pains View AERI Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View AERI Stock Mentions - StockTwits PennyStocks View AERI Stock Mentions - PennyStockTweets
Twitter View AERI Stock Mentions - Twitter Invest Hub View AERI Investment Forum News - Investor Hub
Yahoo View AERI Stock Mentions - Yahoo! Message Board Seeking Alpha View AERI Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for AERI - SECform4.com Insider Cow View Insider Transactions for AERI - Insider Cow
CNBC View AERI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AERI - OTC Markets
Yahoo View Insider Transactions for AERI - Yahoo! Finance NASDAQ View Institutional Holdings for AERI - NASDAQ


Stock Charts

FinViz View AERI Stock Insight & Charts - FinViz.com StockCharts View AERI Investment Charts - StockCharts.com
BarChart View AERI Stock Overview & Charts - BarChart Trading View View AERI User Generated Charts - Trading View


Latest Financial News for AERI

Aerie Pharmaceuticals Announces Appointment of Randall Brown as Director, Payer Marketing
Posted on Monday July 16, 2018

Aerie Pharmaceuticals, Inc. (AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced the appointment of Randall Brown as Director, Payer Marketing, reporting to Deanne Melloy, Aerie’s Vice President of Marketing. Mr. Brown will support the ongoing development and execution of strategies, programs and communication activities for the payer markets. Mr. Brown previously held related positions at Avanir Pharmaceuticals and AstraZeneca.


See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc.
Posted on Thursday July 12, 2018

Short interest is moderately high for AERI with between 10 and 15% of shares outstanding currently on loan. The net inflows of $1.94 billion over the last one-month into ETFs that hold AERI are not among the highest of the last year and have been slowing.


Aerie Pharmaceuticals Has Broken Out on the Upside
Posted on Wednesday June 27, 2018

In this daily bar chart of AERI, below, we can see a decline from December to early May. Despite this decline from $64 to $48 we can see that the daily On-Balance-Volume (OBV) held steady suggesting that traders and investors in AERI did not become aggressive sellers. At the end of May the direction of the OBV line turns up sharply to make a new high.


Aerie Pharmaceuticals Inc’s (NASDAQ:AERI) Shift From Loss To Profit
Posted on Tuesday June 26, 2018

Aerie Pharmaceuticals Inc’s (NASDAQ:AERI): Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases.Read More...


Enter a stock symbol to view the stock details.